Score Overview
Explore the 2021 public Archive ranking β
Where Brainstorm Cell Therapeutics Inc has ranked, year by year
Showing 10 years ranking history by Net Income Growth.
Has not reached the top 50 on Net Income Growth in any year we have ranked.
- BCLI
2014: 99.4% Β· 2021: 95.9% Β· free through 2021 Β· longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-13 | $ 0.77 | β |
1 Year2025-10-13 | $ 0.66 | 17.17% |
5 Years2021-10-13 | $ 47.25 | -98.36% |
10 Years2016-10-13 | $ 34.95 | -97.79% |
20 Years2006-10-13 | $ 65.25 | -98.81% |
| Period | Last Price2026-10-13 | 1 Year2025-10-13 | 5 Years2021-10-13 | 10 Years2016-10-13 | 20 Years2006-10-13 |
|---|---|---|---|---|---|
| Price | $ 0.77 | $ 0.66 | $ 47.25 | $ 34.95 | $ 65.25 |
| Return | β | 17.17% | -98.36% | -97.79% | -98.81% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| 2025 | $ 703K | -$ 10M | $ 29K |
| 2024 | $ 849K | $ 11M | $ 187K |
| 2023 | $ 0.00 | -$ 17M | $ 1M |
| 2022 | $ 0.00 | -$ 23M | $ 2M |
| 2021 | $ 0.00 | -$ 24M | $ 22M |
| 2020 | $ 0.00 | -$ 31M | $ 41M |
| 2019 | -$ 366K | -$ 23M | $ 569K |
| 2018 | $ 0.00 | -$ 13M | $ 7M |
| 2017 | $ 0.00 | -$ 4M | $ 7M |
| 2016 | $ 0.00 | -$ 4M | $ 9M |
| 2015 | $ 0.00 | -$ 8M | $ 15M |
| 2014 | $ 0.00 | -$ 9M | $ 8M |
| 2013 | $ 0.00 | -$ 4M | $ 3M |
| 2012 | $ 0.00 | -$ 3M | $ 4M |
| 2011 | $ 0.00 | -$ 3M | $ 1M |
| 2010 | -$ 2M | $ 93K | |
| 2009 | -$ 1M | $ 1K | |
| 2008 | -$ 3M | $ 2K | |
| 2007 | -$ 6M | $ 86K | |
| 2006 | -$ 3M | $ 60K | |
| 2005 | -$ 3M | $ 290.22K | |
| 2004 | -$ 18M | $ 526.52K | |
| IPO2003 | -$ 73.3K | $ 4.6K |

Brainstorm Cell Therapeutics Inc fundamental performance
Across Brainstorm Cell Therapeutics Inc's full reported history, from 2003 to 2025, net income went from -$ 73.3K to -$ 10M. Revenue increased in 14% of the years measured; net income in 50%.
Membership
Continue BCLIβs history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,125 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio




